125 related articles for article (PubMed ID: 20610884)
1. Pharmacokinetic and pharmacodynamic analysis of acetylcholinesterase inhibition by distigmine bromide in rats.
Ito Y; Harada T; Fushimi K; Kagawa Y; Oka H; Nakazawa H; Homma R; Kato Y; Yamada S
Drug Metab Pharmacokinet; 2010; 25(3):254-61. PubMed ID: 20610884
[TBL] [Abstract][Full Text] [Related]
2. Effect of distigmine bromide on the central cholinergic system.
Nakayama K; Katsu H; Kitazumi K
J Psychopharmacol; 2009 Mar; 23(2):190-3. PubMed ID: 18515453
[TBL] [Abstract][Full Text] [Related]
3. Distigmine Bromide Produces Sustained Potentiation of Guinea-Pig Urinary Bladder Motility by Inhibiting Cholinesterase Activity.
Obara K; Chino D; Tanaka Y
Biol Pharm Bull; 2017; 40(6):807-814. PubMed ID: 28566624
[TBL] [Abstract][Full Text] [Related]
4. Long-Lasting Inhibitory Effects of Distigmine on Recombinant Human Acetylcholinesterase Activity.
Obara K; Chino D; Tanaka Y
Biol Pharm Bull; 2017; 40(10):1739-1746. PubMed ID: 28966245
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of acetylcholinesterase by distigmine bromide (Ubretid).
Breuel HP; Bohn-Olszewsky W; Engelsen SJ; Samhaber EM; Niklaus H
Int J Clin Pharmacol Ther Toxicol; 1993 May; 31(5):230-5. PubMed ID: 8100221
[TBL] [Abstract][Full Text] [Related]
6. Absolute bioavailability, pharmacokinetics, renal and biliary clearance of distigmine after a single oral dose in comparison to i.v. administration of 14C-distigmine-bromide in healthy volunteers.
Vree TB; Waitzinger J; Hammermaier A; Radhofer-Welte S
Int J Clin Pharmacol Ther; 1999 Aug; 37(8):393-403. PubMed ID: 10475142
[TBL] [Abstract][Full Text] [Related]
7. Sustainable Effects of Distigmine Bromide on Urinary Bladder Contractile Function.
Obara K; Tanaka Y
Pharmacology; 2020; 105(3-4):135-144. PubMed ID: 31614352
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between cholinergic symptoms caused by distigmine and the activities of serum AChE and BChE].
Koga M; Miyata H; Tsuno N; Nakayama K; Ushijima S; Tanaka Y; Hiraga Y; Kobayashi N
Nihon Shinkei Seishin Yakurigaku Zasshi; 1997 Jun; 17(3):143-7. PubMed ID: 9278940
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery.
Dow J; Dulery BD; Hornsperger JM; Di Francesco GF; Keshary P; Haegele KD
Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078
[TBL] [Abstract][Full Text] [Related]
10. [Three cases of cholinergic crisis in which serum distigmine bromide concentrations were measured].
Onodera M; Fujino Y; Inoue Y; Endo S; Fujita Y
Chudoku Kenkyu; 2008 Jan; 21(1):75-81. PubMed ID: 18277557
[TBL] [Abstract][Full Text] [Related]
11. Effects of a peripheral cholinesterase inhibitor on cytokine production and autonomic nervous activity in a rat model of sepsis.
Setoguchi D; Yatsuki H; Sadahiro T; Nakamura M; Hirayama Y; Watanabe E; Tateishi Y; Oda S
Cytokine; 2012 Feb; 57(2):238-44. PubMed ID: 22138106
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of muscarinic and nicotinic receptor binding activities of distigmine to treat detrusor underactivity.
Harada T; Fushimi K; Kato A; Ito Y; Nishijima S; Sugaya K; Yamada S
Biol Pharm Bull; 2010; 33(4):653-8. PubMed ID: 20410601
[TBL] [Abstract][Full Text] [Related]
13. The Long-Lasting Enhancing Effect of Distigmine on Acetylcholine-Induced Contraction of Guinea Pig Detrusor Smooth Muscle Correlates with Its Anticholinesterase Activity.
Obara K; Ogawa T; Chino D; Tanaka Y
Biol Pharm Bull; 2017; 40(7):1092-1100. PubMed ID: 28674252
[TBL] [Abstract][Full Text] [Related]
14. [A case of acute distigmine bromide intoxication in the therapeutic dosage for treatment of underactive neurogenic bladder].
Tada M; Fujita N; Umeda M; Koike H; Nagai H
No To Shinkei; 2004 May; 56(5):415-9. PubMed ID: 15279199
[TBL] [Abstract][Full Text] [Related]
15. Physiologically-Based Pharmacokinetic and Pharmacodynamic Modeling for the Inhibition of Acetylcholinesterase by Acotiamide, A Novel Gastroprokinetic Agent for the Treatment of Functional Dyspepsia, in Rat Stomach.
Yoshii K; Iikura M; Hirayama M; Toda R; Kawabata Y
Pharm Res; 2016 Feb; 33(2):292-300. PubMed ID: 26350104
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic analysis of contractile potentiation by cholinesterase inhibitors in rats.
Yamamoto K; Sawada Y; Iga T
J Pharmacokinet Biopharm; 1996 Aug; 24(4):327-48. PubMed ID: 9044164
[TBL] [Abstract][Full Text] [Related]
17. A Physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model for the organophosphate insecticide chlorpyrifos in rats and humans.
Timchalk C; Nolan RJ; Mendrala AL; Dittenber DA; Brzak KA; Mattsson JL
Toxicol Sci; 2002 Mar; 66(1):34-53. PubMed ID: 11861971
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, Biological Evaluation and Molecular Docking Study of Hydrazone-Containing Pyridinium Salts as Cholinesterase Inhibitors.
Parlar S; Bayraktar G; Tarikogullari AH; Alptüzün V; Erciyas E
Chem Pharm Bull (Tokyo); 2016; 64(9):1281-7. PubMed ID: 27581632
[TBL] [Abstract][Full Text] [Related]
19. [Bowel obstruction-induced cholinergic crisis with progressive respiratory failure following distigmine bromide treatment].
Kobayashi K; Sekiguchi H; Sato N; Hirose Y
Chudoku Kenkyu; 2016 Mar; 29(1):26-9. PubMed ID: 27255021
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of novel coumarin-pyridinium hybrids: In vitro cholinesterase inhibitory activity.
Vafadarnejad F; Mahdavi M; Karimpour-Razkenari E; Edraki N; Sameem B; Khanavi M; Saeedi M; Akbarzadeh T
Bioorg Chem; 2018 Apr; 77():311-319. PubMed ID: 29421707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
